To compare IVF outcome in ovarian stimulation protocols with recombinant FSH plus recombinant LH versus hMG, 122 patients were randomized into two study groups: group A, patients treated with urinary hMG, and group B, patients treated with rFSH plus rLH. The two groups proved to be comparable to the main IVF outcome (pregnancy rate, implantation rate, oocytes, and embryos quality), with an increasing risk of ovarian hyperstimulation in the Pergoveris group. Copyright © 2010 American Society for Reproductive Medicine, Published by Elsevier Inc.
Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: A multicenter, prospective, randomized controlled trial / Pacchiarotti, Arianna; Marco, Sbracia; Frega, Antonio; Helmy, Selman; Leonardo, Rinaldi; Pacchiarotti, Alessandro. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - 94:6(2010), pp. 2467-2469. [10.1016/j.fertnstert.2010.04.035]
Urinary hMG (Meropur) versus recombinant FSH plus recombinant LH (Pergoveris) in IVF: A multicenter, prospective, randomized controlled trial
PACCHIAROTTI, ARIANNA;FREGA, Antonio;PACCHIAROTTI, ALESSANDRO
2010
Abstract
To compare IVF outcome in ovarian stimulation protocols with recombinant FSH plus recombinant LH versus hMG, 122 patients were randomized into two study groups: group A, patients treated with urinary hMG, and group B, patients treated with rFSH plus rLH. The two groups proved to be comparable to the main IVF outcome (pregnancy rate, implantation rate, oocytes, and embryos quality), with an increasing risk of ovarian hyperstimulation in the Pergoveris group. Copyright © 2010 American Society for Reproductive Medicine, Published by Elsevier Inc.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
